The Serum Institute plans to manufacture 100 million Covishield vaccines a month from June. Meanwhile, the SII is making Novavax vaccine, but its regulatory clearance from US is awaited. Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India
The Serum Institute plans to manufacture 100 million Covishield vaccines a month from June. Meanwhile, the SII is making Novavax vaccine, but its regulatory clearance from US is awaited. Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India
No comments:
Post a Comment